← Back to previous contentYou are here: Pre-Launch, Launch & Lifecycle
S&P · Pre-Launch, Launch & Lifecycle

Early clarity protects later investment.

From Phase IIIa onward, decision density, investment, and cross-functional dependencies increase. S&P connects clinical and medical evidence with market, customer, access, competitive, resource, and organizational reality.

Pre-Launch, Launch & Lifecycle

Pre-launch readiness

We support market and customer understanding, stakeholder prioritization, value proposition, medical and commercial alignment, evidence and access questions, scenarios, business planning, readiness, and resource implications.

Management model

Align intelligence and resources with lifecycle gates

The need for intelligence does not end at launch. Evidence sufficiency, access readiness, investment exposure, and resource allocation change at every lifecycle gate.

Management should increase exposure only when the evidence and execution case support the next level of commitment.

Align intelligence and resources with lifecycle gatesOriginal graphic in English.
What the figure means for management

Each gate becomes a risk-adjusted decision rather than a calendar milestone.

Concrete S&P contribution

S&P defines continue, accelerate, adapt, partner, hold, and stop criteria, reviews changed assumptions, and connects them with positioning, teams, and resources.

Pre-Launch, Launch & Lifecycle

Launch readiness

In launch situations, we assess whether positioning, segmentation, messages, medical and commercial activities, customer services, governance, and performance management are aligned with the factors that actually drive success.

Pre-Launch, Launch & Lifecycle

Lifecycle optimization

Lifecycle optimization extends beyond indication expansion or price. We examine perception, differentiation, services, customer orientation, resources, competition, new target groups, and implementation quality.

Boundary

S&P does not provide operational trial design, recruitment, or monitoring, and does not offer preclinical or Phase I consulting as a standard service.

Assess a readiness or lifecycle situation

ICCBA across the product lifecycle

ICCBA across the product lifecycleOriginal graphic in English.